81
66
Growth Score
-5 pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
504590
NaviFUS is a provider of novel platform solutions that enables the safe and precise delivery of CNS drugs to target tumor tissues.
- Arthur Lung: Chief Executive Officer
About the Company
As a biotech company, NaviFUS provides novel platform solutions for enhancing the delivery of oncology drugs across the blood-brain barrier. The company's product NaviFUS System utilizes non-invasive ultrasound energy, the NaviFUS System increases BBB permeability transiently and safely, facilitating targeted delivery of small or large
molecular CNS drugs. The company's focus is on helping CNS disease patients globally by supplying therapeutic ultrasound technologies for clinical use through partnerships with global pharmaceutical companies.
